Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7205081> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q7205081 subject Q13245314.
- Q7205081 subject Q7162167.
- Q7205081 subject Q8264595.
- Q7205081 subject Q8522217.
- Q7205081 abstract "Plomestane (INN, USAN; MDL-18,962), also referred to as propargylestrenedione (PED), is a steroidal, irreversible aromatase inhibitor which was under development by Marion Merrell Dow/Hoechst Marion Russell (now Hoechst AG) as an antineoplastic agent for the treatment of breast cancer. It was found to be effective in preclinical studies and was also found to produce few adverse effects in human clinical trials, significantly reducing estrogen levels with a single administration. However, development of the drug for clinical use was halted due to "technical issues" and it was never marketed.".
- Q7205081 atcPrefix "None".
- Q7205081 casNumber "77016-85-4".
- Q7205081 iupacName "10H-(2-propynyl)-estr-4-ene-3,17-dione".
- Q7205081 pubchem "9904788".
- Q7205081 thumbnail Plomestane.svg?width=300.
- Q7205081 wikiPageWikiLink Q128581.
- Q7205081 wikiPageWikiLink Q13245314.
- Q7205081 wikiPageWikiLink Q177911.
- Q7205081 wikiPageWikiLink Q2047938.
- Q7205081 wikiPageWikiLink Q277954.
- Q7205081 wikiPageWikiLink Q3040305.
- Q7205081 wikiPageWikiLink Q30612.
- Q7205081 wikiPageWikiLink Q427492.
- Q7205081 wikiPageWikiLink Q4926095.
- Q7205081 wikiPageWikiLink Q542511.
- Q7205081 wikiPageWikiLink Q5489637.
- Q7205081 wikiPageWikiLink Q7162167.
- Q7205081 wikiPageWikiLink Q7239206.
- Q7205081 wikiPageWikiLink Q824258.
- Q7205081 wikiPageWikiLink Q8264595.
- Q7205081 wikiPageWikiLink Q8522217.
- Q7205081 wikiPageWikiLink Q974135.
- Q7205081 atcPrefix "None".
- Q7205081 casNumber "77016".
- Q7205081 iupacName "10".
- Q7205081 pubchem "9904788".
- Q7205081 type ChemicalSubstance.
- Q7205081 type Drug.
- Q7205081 type ChemicalObject.
- Q7205081 type Thing.
- Q7205081 type Q8386.
- Q7205081 comment "Plomestane (INN, USAN; MDL-18,962), also referred to as propargylestrenedione (PED), is a steroidal, irreversible aromatase inhibitor which was under development by Marion Merrell Dow/Hoechst Marion Russell (now Hoechst AG) as an antineoplastic agent for the treatment of breast cancer. It was found to be effective in preclinical studies and was also found to produce few adverse effects in human clinical trials, significantly reducing estrogen levels with a single administration.".
- Q7205081 label "Plomestane".
- Q7205081 depiction Plomestane.svg.